Furthermore, short-term treatment with PKCγ C1B domain peptides decreases anchorage-independent growth in the colon cancer cell line COLO205, while increasing expression of other PKC isozymes and p53 (Kawabata et al., 2012). This evidence concerns the gene PRKCG and malignant colon neoplasm.